Press Release – September 6, 2016
Chaperone Therapeutics garners National Institutes of Health Award to validate neuronal protective technology in Noise-Induced Hearing Loss

Press Release – February 8, 2016
Chaperone Therapeutics Founder’s groundbreaking research on Heat Shock Transcription Factors published in Nature journal

Press Release – September 22, 2015
Chaperone Therapeutics and the ALS Therapy Development Institute Host Webinar on Partnership to validate Chaperone’s therapies in Amyotropic Lateral Sclerosis

Press Release – September 04, 2015
Chaperone Therapeutics and Senhwa Biosciences Announce Licensing Deal

Press Release – August 10, 2015
Chaperone Therapeutics and ALS Therapy Development Institute Enter into Research Partnership